Verastem Oncology (VSTM) Misses Q3 EPS by 54c
Verastem Oncology (NASDAQ: VSTM) reported Q3 EPS of ($0.54). Revenue for the quarter came in at $11.24 million.
For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.
Verastem Oncology (NASDAQ: VSTM) reported Q3 EPS of ($0.54). Revenue for the quarter came in at $11.24 million.
For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.